NCT01613170View on ClinicalTrials.gov

Premarin Versus Toviaz for Treatment of Overactive Bladder

PHASE4UnknownINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2018

Study Completion Date

December 31, 2018

Conditions

Overactive Bladder

Interventions

DRUG

Toviaz

Toviaz 4mg daily

DRUG

Premarin

Premarin cream 1 g per vagina twice weekly

DRUG

Placebo cream

Placebo cream 1 g per vagina twice weekly, to mimic Premarin cream

Trial Locations (1)

33331

RECRUITING

Cleveland Clinic Florida, Weston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

The Cleveland Clinic

OTHER